Bio-Rad Laboratories, Inc. Class A Common Stock vs Equinor ASA — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Equinor ASA trades at $40.93 (market cap $97.58B). The key difference: Equinor ASA is far larger — about 10.3× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Equinor ASA pays a 3.81% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | EQNR | |
|---|---|---|
Market Cap | $9.43B | $97.58B |
Sector | Health | Energy |
52-Week High | $356.25 | $42.40 |
52-Week Low | $241.71 | $22.41 |
Enterprise Value | $9.18B | $106.28B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →